Lifecore Biomedical Inc.

NASDAQ: LFCR · Real-Time Price · USD
7.37
-0.05 (-0.67%)
At close: Aug 15, 2025, 3:59 PM
7.37
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Lifecore Biomedical Cash Flow Statement

Financials in USD. Fiscal year is June - May.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending May 25, 2025 May 26, 2024 May 28, 2023 May 29, 2022 May 31, 2021
Net Income
-38.72M 9.33M -38.2M -35.88M -2.87M
Depreciation & Amortization
8.03M 8.86M 13.18M 18.06M 8.61M
Stock-Based Compensation
10.16M 6.2M 3.61M 2.64M 3.31M
Other Working Capital
-8.45M 4.36M 7.62M -3.67M 12.45M
Other Non-Cash Items
25.02M -20.93M -18.46M 706K 6.43M
Deferred Income Tax
n/a 163K 357K -6.83M -7.89M
Change in Working Capital
-4.7M -3.85M 22.07M -3.1M 8.89M
Operating Cash Flow
-206K -217K -17.44M -24.4M 16.47M
Capital Expenditures
-13.41M -17.92M -20.76M -28.13M -23.77M
Cash Acquisitions
7M n/a 16.61M 63.66M 12.91M
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 45.1M n/a
Other Investing Acitivies
n/a n/a -658K 1.14M -1.45M
Investing Cash Flow
-6.42M -17.92M -4.81M 81.77M -12.31M
Debt Repayment
-18.56M 2.75M 3.12M -55.41M 7.47M
Common Stock Repurchased
n/a -152K n/a -789K -405K
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
1.13M 4.04M -6.32M -821K -10.48M
Financial Cash Flow
6.42M 7.51M 39.7M -57.02M -3.42M
Net Cash Flow
-197K -10.63M 17.45M 348K 742K
Free Cash Flow
-13.62M -18.14M -55.22M -52.53M -8.75M